Biotech entity
Every one of those 1 sits in a single category, pharma. Transient Global Amnesia (TGA) is most often covered alongside Aspen Ideas Festival, which appears in 1 of these 1 story. The tracked stories average 13 original sources each. Transient Global Amnesia (TGA) appears in 1 tracked Biotech story from July 12, 2026.
Last mentioned: Jul 12, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Every one of those 1 sits in a single category, pharma. Transient Global Amnesia (TGA) is most often covered alongside Aspen Ideas Festival, which appears in 1 of these 1 story. The tracked stories average 13 original sources each. Transient Global Amnesia (TGA) appears in 1 tracked Biotech story from July 12, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 17 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Transient Global Amnesia (TGA). Shared-story counts are live from our verified record — not editorial picks.
The transient global amnesia episode experienced by Katie Couric spotlights a rare condition with no targeted therapy, exposing a gap in CNS drug pipelines. The condition’s links to migraines and stress suggest repurposing opportunities, but market size and clinical trial hurdles remain obstacles.
Transient Global Amnesia (TGA) is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
